EurekaMag.com logo
+ Site Statistics
References:
54,215,046
Abstracts:
30,230,908
PMIDs:
28,215,208
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Identification of Risk Factors for Chemotherapy-Related 30-Day Readmissions



Identification of Risk Factors for Chemotherapy-Related 30-Day Readmissions



Journal of the National Comprehensive Cancer Network 13(6): 748-754



The goal of this study was to develop a method for practitioners to evaluate both quality of care delivered to patients receiving chemotherapy and illicit risk factors for 30-day chemotherapy-related readmissions (CRR). Midas+ DataVision Readmission Tool Pack (Version 2.x) was used to retrospectively identify patients who received inpatient chemotherapy from April 2010 through May 2013. The population was screened for unscheduled admissions within 30 days after discharge. A multidisciplinary team was used to attribute readmissions to chemotherapy administration. Demographic information and oncology-specific characteristics were collected. The CRR rate and relative risk for readmission were calculated for each characteristic. A baseline CRR rate of 11.1% was established. Risk factors associated with an increased risk for experiencing a CRR included age of 65 years or older, hematologic cancer diagnosis, first cycle chemotherapy, Medicare coverage, discharge to a skilled nursing facility, and anthracycline administration. A baseline CRR rate was established. Institution-specific 30-day CRR risk factors were elucidated. Modifiable risk factors included discharge to a skilled nursing facility and administration of an anthracycline. Further investigation for opportunities for quality improvement in these 2 risk factors is a topic for future research. Expanded research into chemotherapy-related toxicities requiring inpatient admission/readmission outside of clinical trials is warranted.

(PDF emailed within 1 workday: $29.90)

Accession: 058037139

Download citation: RISBibTeXText

PMID: 26085390



Related references

Multivariable regression analysis of febrile neutropenia occurrence in early breast cancer patients receiving chemotherapy assessing patient-related, chemotherapy-related and genetic risk factors. Bmc Cancer 14(): 201-201, 2014

Risk factors for unplanned readmissions in older adult trauma patients in Washington State: a competing risk analysis. Journal of the American College of Surgeons 220(3): 330-338, 2015

A model to estimate the risk of breast cancer-related lymphedema: combinations of treatment-related factors of the number of dissected axillary nodes, adjuvant chemotherapy, and radiation therapy. International Journal of Radiation Oncology, Biology, Physics 86(3): 498-503, 2013

Risk factors for febrile neutropenia during chemotherapy for HIV-related lymphoma. Journal of Korean Medical Science 27(12): 1468-1471, 2013

Risk factors associated with 30-day asthma readmissions. Journal of Asthma 53(7): 684-690, 2016

Risk factors associated with multiple hospital readmissions. Home Care Provider 1(2): 83-85, 1996

Pneumonia readmissions: risk factors and implications. Ochsner Journal 14(4): 649-654, 2015

Risk factors for nonelective hospital readmissions. Journal of General Internal Medicine 11(12): 762-764, 1996

Identification of risk factors for requiring transfusion during front-line chemotherapy for ovarian cancer. Gynecologic Oncology 81(3): 485-489, 2001

A survey of factors related to mental hospital readmissions. Hospital & Community Psychiatry 26(11): 749-751, 1975

Risk factors for hospital readmissions in HIV-infected adults. Clinical Infectious Diseases 25(2): 443, 1997

Incidence And Risk Factors For 30-Day Readmissions After Hip Fracture Surgery. Iowa Orthopaedic Journal 36(): 155-160, 2016

Risk Factors for 30-Day Readmissions of Individuals with Decompensated Cirrhosis. Southern Medical Journal 108(11): 682-687, 2016

Risk Factors of Readmissions Among Severe Sepsis Survivors. Critical Care Medicine 43(10): E461-E461, 2015

The Identification of Seniors at Risk screening tool is useful for predicting acute readmissions. Danish Medical Journal 61(5): A4828-A4828, 2015